- Home
- RDHL vs ORIS Comparison
RDHL vs ORIS Comparison
Compare RDHL & ORIS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RDHL | ORIS |
|---|---|---|
| Founded | 2009 | 2014 |
| Country | Israel | China |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Farming/Seeds/Milling |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.9M | 4.6M |
| IPO Year | N/A | 2024 |
Fundamental Metrics
Financial Performance| Metric | RDHL | ORIS |
|---|---|---|
| Price | $1.21 | $0.12 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 68.5K | ★ 2.0M |
| Earning Date | 09-05-2025 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.00 |
| Revenue | $9,550,000.00 | ★ $12,317,000.00 |
| Revenue This Year | $381.91 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $541.07 |
| Revenue Growth | ★ 157.62 | N/A |
| 52 Week Low | $1.01 | $0.08 |
| 52 Week High | $7.44 | $2.85 |
Technical Indicators
Market Signals| Indicator | RDHL | ORIS |
|---|---|---|
| Relative Strength Index (RSI) | 49.36 | 42.73 |
| Support Level | $1.18 | $0.11 |
| Resistance Level | $1.26 | $0.13 |
| Average True Range (ATR) | 0.05 | 0.01 |
| MACD | 0.03 | 0.00 |
| Stochastic Oscillator | 78.00 | 38.82 |
Price Performance
Historical ComparisonAbout RDHL Redhill Biopharma Ltd.
Redhill Biopharma Ltd is a specialty biopharmaceutical company focused on gastrointestinal diseases. The company is dedicated to advancing its development pipeline of clinical-stage therapeutic candidates. It also commercializes GI-related products in the U.S., including Talicia (omeprazole, amoxicillin, and rifabutin) and Aemcolo (rifamycin). Currently, the company's pipeline consists of five therapeutic candidates: Opaganib, RHB-107, RHB-102, RHB-204, and RHB-104, the majority of which are in clinical development.
About ORIS Oriental Rise Holdings Limited Ordinary Shares
Oriental Rise Holdings Ltd is an integrated supplier of tea products in China. It is principally engaged in the business of planting, cultivating, processing, and selling processed tea. The company currently produces and sells three categories of products: roughly processed white tea, roughly processed black tea, and refined tea. The company's business operations are vertically integrated, covering cultivation, processing of tea leaves, and the sale of tea products to tea business operators and end-user retail customers. Geographically, the company generates all of its revenue from its business in the People's Republic of China (the PRC).